Through isolating the murine PDGFRα+ and F4/80− CAFs at the border of tumor, and co-culturing with EC cells with RB treatment, we found RB could cause obvious tumor suppression on EC cell malignant phenotype, suggesting that RB could indeed suppress the malignancy of EC cells by affecting the adjacent fibroblasts. This evidence concerns the gene PDGFRA and neoplasm.